Altered states: selectively drugging the Hsp90 cancer chaperone
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (2) , 47-51
- https://doi.org/10.1016/j.molmed.2003.12.005
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitorsNature, 2003
- The rules of attractionNature, 2003
- Activation of the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone Aha1Molecular Cell, 2002
- Addiction to Oncogenes--the Achilles Heal of CancerScience, 2002
- Hsp90 as a capacitor of phenotypic variationNature, 2002
- Stimulation of the weak ATPase activity of human Hsp90 by a client protein 1 1Edited by G. von HeijneJournal of Molecular Biology, 2002
- HSP90 as a new therapeutic target for cancer therapy: the story unfoldsExpert Opinion on Biological Therapy, 2002
- The Hallmarks of CancerCell, 2000
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999
- Tandem [3,3]-Sigmatropic Rearrangements in an Ansamycin: Stereospecific Conversion of an (S)-Allylic Alcohol to an (S)-Allylic Amine DerivativeThe Journal of Organic Chemistry, 1994